Assessing the healthcare epidemiology environment—A roadmap for SHEA’s future

2021 ◽  
pp. 1-4
Author(s):  
David K. Henderson ◽  
Corey A. Forde ◽  
Sarah Haessler ◽  
Ibukunoluwa C. Kalu ◽  
Latania K. Logan ◽  
...  
Keyword(s):  
Healthcare Epidemiology

Interfacility transfer communication of multidrug-resistant organism colonization or infection status: Practices and barriers in the acute-care setting

2021 ◽  
pp. 1-6
Author(s):  
Katherine D. Ellingson ◽  
Brie N. Noble ◽  
Genevieve L. Buser ◽  
Graham M. Snyder ◽  
Jessina C. McGregor ◽  
...  
Keyword(s):  
Acute Care ◽  
Infection Prevention ◽  
Multidrug Resistant ◽  
Research Network ◽  
Resistant Organism ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Hospital Size ◽  
Academic Affiliation ◽  
Healthcare Epidemiology

Abstract Objective: To describe interfacility transfer communication (IFTC) methods for notification of multidrug-resistant organism (MDRO) status in a diverse sample of acute-care hospitals. Design: Cross-sectional survey. Participants: Hospitals within the Society for Healthcare Epidemiology of America (SHEA) Research Network (SRN). Methods: SRN members completed an electronic survey on protocols and methods for IFTC. We assessed differences in IFTC frequency, barriers, and perceived benefit by presence of an IFTC protocol. Results: Among 136 hospital representatives who were sent the survey, 54 (40%) responded, of whom 72% reported having an IFTC protocol in place. The presence of a protocol did not differ significantly by hospital size, academic affiliation, or international status. Of those with IFTC protocols, 44% reported consistent notification of MDRO status (>75% of the time) to receiving facilities, as opposed to 13% from those with no IFTC protocol (P = .04). Respondents from hospitals with IFTC protocols reported significantly fewer barriers to communication compared to those without (2.8 vs 4.3; P = .03). Overall, however, most respondents (56%) reported a lack of standardization in communication. Presence of an IFTC protocol did not affect whether respondents perceived IFTC protocols as having a significant impact on infection prevention or antimicrobial stewardship. Conclusions: Most respondents reported having an IFTC protocol, which was associated with reduced communication barriers at transfer. Standardization of protocols and clarity about expectations for sending and receipt of information related to MDRO status may facilitate IFTC and promote appropriate and timely infection prevention practices.

scholarly journals Implementation Science: How to Jump-Start Infection Prevention

2010 ◽  
Vol 31 (S1) ◽  
pp. S14-S17 ◽  
Author(s):  
Sanjay Saint ◽  
Joel D. Howell ◽  
Sarah L. Krein
Keyword(s):  
Patient Safety ◽  
Implementation Science ◽  
Infection Prevention ◽  
Theory And Practice ◽  
Evidence Based ◽  
Clinical Model ◽  
Healthcare Epidemiology

Implementing evidence-based infection prevention practices is challenging. Implementation science, which is the study of methods promoting the uptake of evidence into practice, addresses the gap between theory and practice. Just as healthcare epidemiology has emerged as a paradigm for patient safety, infection prevention may serve as a clinical model for implementation researchers.

Guidelines for the Management of Intravascular Catheter-Related Infections

2001 ◽  
Vol 22 (4) ◽  
pp. 222-242 ◽  
Author(s):  
Leonard A. Mermel ◽  
Barry M. Farr ◽  
Robert J. Sherertz ◽  
Issam I. Raad ◽  
Naomi O'Grady ◽  
...  
Keyword(s):  
Critical Care ◽  
The United States ◽  
Underlying Disease ◽  
Critical Care Medicine ◽  
Intravascular Catheter ◽  
Coagulase Negative Staphylococci ◽  
Pulmonary Artery Catheters ◽  
Potential Pathogen ◽  
Adults And Children ◽  
Healthcare Epidemiology

These guidelines from the Infectious Diseases Society of America (IDSA), the American College of Critical Care Medicine (for the Society of Critical Care Medicine), and the Society for Healthcare Epidemiology of America contain recommendations for the management of adults and children with, and diagnosis of infections related to, peripheral and nontunneled central venous catheters (CVCs), pulmonary artery catheters, tunneled central catheters, and implantable devices. The guidelines, written for clinicians, contain IDSA evidence-based recommendations for assessment of the quality and strength of the data. Recommendations are presented according to the type of catheter, the infecting organism, and the associated complications.Intravascular catheter-related infections are a major cause of morbidity and mortality in the United States. Coagulase-negative staphylococci,Staphylococcus aureus, aerobic gram-negative bacilli, andCandida albicansmost commonly cause catheter-related bloodstream infection. Management of catheter-related infection varies according to the type of catheter involved. After appropriate cultures of blood and catheter samples are done, empirical iv antimicrobial therapy should be initiated on the basis of clinical clues, the severity of the patient's acute illness, underlying disease, and the potential pathogen (s) involved. In most cases of nontunneled CVC-related bacteremia and fungemia, the CVC should be removed.

Quality Improvement in Healthcare Epidemiology

2018 ◽  
pp. 30-40
Author(s):  
Mohamad G. Fakih ◽  
Susan MacArthur ◽  
Louise-Marie Dembry
Keyword(s):  
Quality Improvement ◽  
Healthcare Epidemiology

scholarly journals Discordance of SHEA/IDSA Clostridium difficile Disease Severity Scale in Solid Organ Transplant Patients

2017 ◽  
Vol 4 (suppl_1) ◽  
pp. S383-S383 ◽  
Author(s):  
Tiffany Lee ◽  
Christopher McCoy ◽  
Carolyn D Alonso ◽  
Graham M Snyder ◽  
Christin Rogers ◽  
...  
Keyword(s):  
Clostridium Difficile ◽  
Organ Transplant ◽  
Solid Organ Transplant ◽  
Solid Organ ◽  
Research Support ◽  
Transplant Patients ◽  
Cell Counts ◽  
Immunocompromised Status ◽  
White Blood Cell Counts ◽  
Healthcare Epidemiology

Abstract Background Solid organ transplant (SOT) patients are at high risk for Clostridium difficile infections (CDI) due to chronic immunosuppression and a propensity to receive antimicrobials. Management of CDI in SOT patients poses unique challenges as this population has disease-altered clinical and laboratory parameters. The objective of this study was to assess concordance between various CDI severity scales and the Society for Healthcare Epidemiology of America/Infectious Diseases Society of America (SHEA/IDSA) guidelines. Methods This retrospective study included all SOT recipients with a first CDI episode following transplant and time-matched (2:1) to non-SOT patients experiencing first CDI episodes between 2008 and 2016. The primary endpoint was concordance rates of CDI episodes considered mild-moderate or severe/severe-complicated in published CDI scales compared with the SHEA/IDSA guidelines. We also sought to compare the distribution of CDI severity across all scales between SOT and non-SOT patients. Results Overall, 32 SOT patients and 64 non-SOT patients were included. The SOT group had significantly higher leukopenia rates at CDI diagnosis; however, the magnitude of serum creatinine change did not differ between groups. According to the SHEA/IDSA scale, CDI episodes in SOT recipients were categorized as mild-moderate and severe/severe-complicated in 23 (72%) and 9 (28%) patients, respectively. Overall concordance rates among SHEA/IDSA guidelines and other scales ranged from 28% to 72%. Concordance rates were highest for mild-moderate CDI with Belmares and for severe/severe-complicated CDI with ESCMID (Table 1). No scale evenly categorized SOT and non-SOT patients across all severities (Figure 1). Conclusion Severity scales with heavy emphasis on white blood cell counts may not adequately categorize SOT patients. Immunocompromised status may need to be considered on its own when categorizing CDI severity and prescribing therapy. Disclosures C. D. Alonso, Merck: Grant Investigator and Scientific Advisor, Research grant sanofi pasteur: Investigator and Scientific Advisor, Research support GSK: Investigator, Research support; E. B. Hirsch, Merck: Grant Investigator, Grant recipient The Medicines Company: Speaker’s Bureau, Speaker honorarium

scholarly journals Practical Healthcare Epidemiology, 4th Edition

2019 ◽  
Vol 25 (11) ◽  
pp. 2161-2161
Author(s):  
Edward Lifshitz
Keyword(s):  
Healthcare Epidemiology

scholarly journals Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update

2014 ◽  
Vol 35 (S2) ◽  
pp. S48-S65 ◽  
Author(s):  
Erik R. Dubberke ◽  
Philip Carling ◽  
Ruth Carrico ◽  
Curtis J. Donskey ◽  
Vivian G. Loo ◽  
...  
Keyword(s):  
Clostridium Difficile ◽  
Acute Care ◽  
Acute Care Hospitals ◽  
Guidance Document ◽  
Healthcare Associated Infections ◽  
American Hospital ◽  
American Hospital Association ◽  
Healthcare Associated ◽  
Healthcare Epidemiology ◽  
Practical Recommendations

Previously published guidelines are available that provide comprehensive recommendations for detecting and preventing healthcare-associated infections (HAIs). The intent of this document is to highlight practical recommendations in a concise format designed to assist acute care hospitals in implementing and prioritizing their Clostridium difficile infection (CDI) prevention efforts. This document updates “Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals,” published in 2008. This expert guidance document is sponsored by the Society for Healthcare Epidemiology of America (SHEA) and is the product of a collaborative effort led by SHEA, the Infectious Diseases Society of America (IDSA), the American Hospital Association (AHA), the Association for Professionals in Infection Control and Epidemiology (APIC), and The Joint Commission, with major contributions from representatives of a number of organizations and societies with content expertise. The list of endorsing and supporting organizations is presented in the introduction to the 2014 updates.

Sign in / Sign up

Export Citation Format

Share Document